tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW
US Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports
Want to see EW full AI Analyst Report?

Edwards Lifesciences (EW) Ratios

1,953 Followers

Edwards Lifesciences Ratios

EW's free cash flow for Q1 2026 was $0.78. For the 2026 fiscal year, EW's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.42 3.72 4.18 3.38 3.03
Quick Ratio
 3.63 3.09 3.45 2.62 2.17
Cash Ratio
 1.74 1.62 2.02 0.95 0.75
Solvency Ratio
 0.41 0.37 1.45 0.59 0.68
Operating Cash Flow Ratio
 0.96 0.88 0.36 0.75 1.19
Short-Term Operating Cash Flow Coverage
 55.91 65.11 0.00 0.00 0.00
Net Current Asset Value
$ 3.23B$ 3.38B$ 3.29B$ 1.39B$ 610.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.05 0.07 0.08
Debt-to-Equity Ratio
 0.07 0.07 0.07 0.10 0.12
Debt-to-Capital Ratio
 0.06 0.06 0.07 0.09 0.11
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.06 0.08 0.09
Financial Leverage Ratio
 1.29 1.32 1.31 1.41 1.43
Debt Service Coverage Ratio
 49.82 49.49 79.34 78.55 65.45
Interest Coverage Ratio
 0.00 0.00 69.63 81.10 64.98
Debt to Market Cap
 0.01 0.01 0.01 0.01 0.01
Interest Debt Per Share
 1.21 1.21 1.20 1.16 1.16
Net Debt to EBITDA
 -1.25 -1.56 -1.36 -0.29 -0.04
Profitability Margins
Gross Profit Margin
78.01%78.13%79.46%79.30%78.31%
EBIT Margin
20.87%20.98%28.82%27.74%33.32%
EBITDA Margin
22.77%23.56%31.68%30.64%36.42%
Operating Profit Margin
27.62%26.97%25.35%28.49%31.63%
Pretax Profit Margin
20.59%20.98%28.46%27.39%32.84%
Net Profit Margin
17.34%17.69%76.75%27.99%28.28%
Continuous Operations Profit Margin
17.02%17.40%25.66%24.35%28.28%
Net Income Per EBT
84.19%84.33%269.66%102.19%86.11%
EBT Per EBIT
74.55%77.80%112.29%96.15%103.82%
Return on Assets (ROA)
8.20%7.84%31.98%14.98%18.35%
Return on Equity (ROE)
10.55%10.38%41.75%21.09%26.21%
Return on Capital Employed (ROCE)
14.62%13.77%11.94%17.47%23.42%
Return on Invested Capital (ROIC)
12.06%11.40%10.74%15.49%20.09%
Return on Tangible Assets
10.64%9.94%41.32%17.94%22.24%
Earnings Yield
2.36%2.15%9.43%3.03%3.30%
Efficiency Ratios
Receivables Turnover
 6.48 6.65 7.48 6.05 7.70
Payables Turnover
 7.66 5.83 5.66 5.56 5.78
Inventory Turnover
 1.24 1.18 1.03 1.15 1.33
Fixed Asset Turnover
 3.28 3.17 3.05 2.99 3.12
Asset Turnover
 0.47 0.44 0.42 0.54 0.65
Working Capital Turnover Ratio
 1.29 1.25 1.43 2.04 2.55
Cash Conversion Cycle
 8.71 302.08 339.27 312.59 258.05
Days of Sales Outstanding
 56.34 54.87 48.81 60.33 47.41
Days of Inventory Outstanding
 0.00 309.79 354.94 317.92 273.78
Days of Payables Outstanding
 47.63 62.58 64.48 65.66 63.14
Operating Cycle
 56.34 364.66 403.75 378.25 321.19
Cash Flow Ratios
Operating Cash Flow Per Share
 2.35 2.73 0.91 1.48 1.97
Free Cash Flow Per Share
 1.88 2.28 0.49 1.04 1.54
CapEx Per Share
 0.46 0.44 0.42 0.44 0.43
Free Cash Flow to Operating Cash Flow
 0.80 0.84 0.53 0.70 0.78
Dividend Paid and CapEx Coverage Ratio
 5.05 6.13 2.15 3.36 4.60
Capital Expenditure Coverage Ratio
 5.05 6.13 2.15 3.36 4.60
Operating Cash Flow Coverage Ratio
 1.93 2.26 0.77 1.31 1.76
Operating Cash Flow to Sales Ratio
 0.22 0.26 0.10 0.18 0.23
Free Cash Flow Yield
2.37%2.68%0.66%1.36%2.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 42.26 46.44 10.60 32.99 30.35
Price-to-Sales (P/S) Ratio
 7.28 8.22 8.13 9.23 8.58
Price-to-Book (P/B) Ratio
 4.47 4.82 4.43 6.96 7.95
Price-to-Free Cash Flow (P/FCF) Ratio
 42.14 37.34 152.63 73.49 48.44
Price-to-Operating Cash Flow Ratio
 33.99 31.25 81.59 51.64 37.91
Price-to-Earnings Growth (PEG) Ratio
 -0.58 -0.63 0.05 -5.41 14.63
Price-to-Fair Value
 4.47 4.82 4.43 6.96 7.95
Enterprise Value Multiple
 30.76 33.31 24.32 29.85 23.52
Enterprise Value
 44.24B 47.62B 41.90B 45.81B 46.11B
EV to EBITDA
 30.82 33.31 24.32 29.85 23.52
EV to Sales
 7.02 7.85 7.70 9.14 8.57
EV to Free Cash Flow
 40.61 35.67 144.54 72.78 48.36
EV to Operating Cash Flow
 32.56 29.85 77.27 51.14 37.85
Tangible Book Value Per Share
 12.57 12.72 11.89 8.53 7.04
Shareholders’ Equity Per Share
 17.83 17.68 16.73 10.96 9.38
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.10 0.11 0.14
Revenue Per Share
 10.88 10.38 9.10 8.26 8.70
Net Income Per Share
 1.89 1.84 6.98 2.31 2.46
Tax Burden
 0.84 0.84 2.70 1.02 0.86
Interest Burden
 0.99 1.00 0.99 0.99 0.99
Research & Development to Revenue
 0.17 0.18 0.19 0.19 0.18
SG&A to Revenue
 0.34 0.34 0.33 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.02
Income Quality
 1.24 1.49 0.13 0.64 0.80
Currency in USD